Hyperthermia Cancer Treatment Market
Hyperthermia Cancer Treatment Market Analysis By Device (Infrared Devices, Ultrasound, Microwave Devices), By Treatment Method (Loco-regional Method, External & Interstitial), By Application, By End User, By Region - Global Insights 2021 to 2031

- May-2021
- List of Tables : 36
- List of Figures : 89
- 170 Pages
- Healthcare
Table of Content
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Hyperthermia Cancer Treatment Market Forecast
4.4. Global Hyperthermia Cancer Treatment Market Outlook
5. Market Outlook
5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.2. Epidemiology of Cancer Globally/Country
5.3. Reimbursement Scenario
5.4. Regulatory Scenario
5.5. Overview on Combination Cancer Treatment Strategies along with Hyperthermia
6. Global Hyperthermia Cancer Treatment Market Analysis, by Device
6.1. Introduction
6.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device
6.3. Global Hyperthermia Cancer Treatment Market Forecast, by Device
6.3.1. Infrared Hyperthermia Devices
6.3.2. Ultrasound Hyperthermia Devices
6.3.3. Microwave Hyperthermia Devices
6.3.4. Others
6.4. Global Hyperthermia Cancer Treatment Market Analysis, by Device
7. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method
7.1. Introduction
7.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
7.3. Global Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
7.3.1. Locoregional
7.3.1.1. External & Interstitial
7.3.1.2. Intraluminal or Endocavitary Methods
7.3.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
7.3.1.4. Deep Tissue & Regional Perfusion
7.3.2. Whole-body
7.4. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method
8. Global Hyperthermia Cancer Treatment Market Analysis, by Application
8.1. Introduction
8.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
8.3. Global Hyperthermia Cancer Treatment Market Forecast, by Application
8.3.1. Breast Cancer
8.3.2. Liver Cancer
8.3.3. Soft Tissue Sarcoma
8.3.4. Head & Neck Tumors
8.3.5. Prostate Cancer
8.3.6. Others
8.4. Global Hyperthermia Cancer Treatment Market Analysis, by Application
9. Global Hyperthermia Cancer Treatment Market Analysis, by End User
9.1. Introduction
9.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User
9.3. Global Hyperthermia Cancer Treatment Market Forecast, by End User
9.3.1. Hospitals & Specialty Clinics
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Global Hyperthermia Cancer Treatment Market Analysis, by End User
10. Global Hyperthermia Cancer Treatment Market Analysis, by Region
10.1. Global Hyperthermia Cancer Treatment Market Scenario, by Region/Country
10.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Region
10.3. Global Hyperthermia Cancer Treatment Market Forecast, by Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
11. North America Hyperthermia Cancer Treatment Market Analysis
11.1. North America Hyperthermia Cancer Treatment Market Overview
11.2. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country
11.3. North America Hyperthermia Cancer Treatment Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device
11.5. North America Hyperthermia Cancer Treatment Market Forecast, by Device
11.5.1. Infrared Hyperthermia Devices
11.5.2. Ultrasound Hyperthermia Devices
11.5.3. Microwave Hyperthermia Devices
11.5.4. Others
11.6. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
11.7. North America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
11.7.1. Locoregional
11.7.1.1. External & Interstitial
11.7.1.2. Intraluminal or Endocavitary Methods
11.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
11.7.1.4. Deep Tissue & Regional Perfusion
11.7.2. Whole-body
11.8. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
11.9. North America Hyperthermia Cancer Treatment Market Forecast, by Application
11.9.1. Breast Cancer
11.9.2. Liver Cancer
11.9.3. Soft Tissue Sarcoma
11.9.4. Head & Neck Tumors
11.9.5. Prostate Cancer
11.9.6. Others
11.10. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User
11.11. North America Hyperthermia Cancer Treatment Market Forecast, by End User
11.11.1. Hospitals & Specialty Clinics
11.11.2. Ambulatory Surgical Centers
11.11.3. Others
12. Europe Hyperthermia Cancer Treatment Market Analysis
12.1. Europe Hyperthermia Cancer Treatment Market Overview
12.2. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Europe Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device
12.5. Europe Hyperthermia Cancer Treatment Market Forecast, by Device
12.5.1. Infrared Hyperthermia Devices
12.5.2. Ultrasound Hyperthermia Devices
12.5.3. Microwave Hyperthermia Devices
12.5.4. Others
12.6. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
12.7. Europe Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
12.7.1. Locoregional
12.7.1.1. External & Interstitial
12.7.1.2. Intraluminal or Endocavitary Methods
12.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
12.7.1.4. Deep Tissue & Regional Perfusion
12.7.2. Whole-body
12.8. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
12.9. Europe Hyperthermia Cancer Treatment Market Forecast, by Application
12.9.1. Breast Cancer
12.9.2. Liver Cancer
12.9.3. Soft Tissue Sarcoma
12.9.4. Head & Neck Tumors
12.9.5. Prostate Cancer
12.9.6. Others
12.10. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User
12.11. Europe Hyperthermia Cancer Treatment Market Forecast, by End User
12.11.1. Hospitals & Specialty Clinics
12.11.2. Ambulatory Surgical Centers
12.11.3. Others
13. Asia Pacific Hyperthermia Cancer Treatment Market Analysis
13.1. Asia Pacific Hyperthermia Cancer Treatment Market Overview
13.2. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
13.3.1. Japan
13.3.2. China
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device
13.5. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Device
13.5.1. Infrared Hyperthermia Devices
13.5.2. Ultrasound Hyperthermia Devices
13.5.3. Microwave Hyperthermia Devices
13.5.4. Others
13.6. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
13.7. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
13.7.1. Locoregional
13.7.1.1. External & Interstitial
13.7.1.2. Intraluminal or Endocavitary Methods
13.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
13.7.1.4. Deep Tissue & Regional Perfusion
13.7.2. Whole-body
13.8. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
13.9. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Application
13.9.1. Breast Cancer
13.9.2. Liver Cancer
13.9.3. Soft Tissue Sarcoma
13.9.4. Head & Neck Tumors
13.9.5. Prostate Cancer
13.9.6. Others
13.10. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User
13.11. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by End User
13.11.1. Hospitals & Specialty Clinics
13.11.2. Ambulatory Surgical Centers
13.11.3. Others
14. Latin America Hyperthermia Cancer Treatment Market Analysis
14.1. Latin America Hyperthermia Cancer Treatment Market Overview
14.2. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Latin America Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device
14.5. Latin America Hyperthermia Cancer Treatment Market Forecast, by Device
14.5.1. Infrared Hyperthermia Devices
14.5.2. Ultrasound Hyperthermia Devices
14.5.3. Microwave Hyperthermia Devices
14.5.4. Others
14.6. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
14.7. Latin America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
14.7.1. Locoregional
14.7.1.1. External & Interstitial
14.7.1.2. Intraluminal or Endocavitary Methods
14.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
14.7.1.4. Deep Tissue & Regional Perfusion
14.7.2. Whole-body
14.8. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
14.9. Latin America Hyperthermia Cancer Treatment Market Forecast, by Application
14.9.1. Breast Cancer
14.9.2. Liver Cancer
14.9.3. Soft Tissue Sarcoma
14.9.4. Head & Neck Tumors
14.9.5. Prostate Cancer
14.9.6. Others
14.10. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User
14.11. Latin America Hyperthermia Cancer Treatment Market Forecast, by End User
14.11.1. Hospitals & Specialty Clinics
14.11.2. Ambulatory Surgical Centers
14.11.3. Others
15. Middle East & Africa Hyperthermia Cancer Treatment Market Analysis
15.1. Middle East & Africa Hyperthermia Cancer Treatment Market Overview
15.2. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
15.3. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
15.4. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device
15.5. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Device
15.5.1. Infrared Hyperthermia Devices
15.5.2. Ultrasound Hyperthermia Devices
15.5.3. Microwave Hyperthermia Devices
15.5.4. Others
15.6. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
15.7. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
15.7.1. Locoregional
15.7.1.1. External & Interstitial
15.7.1.2. Intraluminal or Endocavitary Methods
15.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
15.7.1.4. Deep Tissue & Regional Perfusion
15.7.2. Whole-body
15.8. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
15.9. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Application
15.9.1. Breast Cancer
15.9.2. Liver Cancer
15.9.3. Soft Tissue Sarcoma
15.9.4. Head & Neck Tumors
15.9.5. Prostate Cancer
15.9.6. Others
15.10. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User
15.11. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by End User
15.11.1. Hospitals & Specialty Clinics
15.11.2. Ambulatory Surgical Centers
15.11.3. Others
16. Competition Landscape
16.1. Competition Matrix
16.2. Company Profiles
16.2.1. Pyrexar Medical
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. SWOT Analysis
16.2.1.4. Strategic Overview
16.2.2. Celsius42 GmbH
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. SWOT Analysis
16.2.2.4. Strategic Overview
16.2.3. Hydrosun GmbH
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. SWOT Analysis
16.2.3.4. Strategic Overview
16.2.4. OncothermKft
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. SWOT Analysis
16.2.4.4. Strategic Overview
16.2.5. AndromedicS.r.l.
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. SWOT Analysis
16.2.5.4. Strategic Overview
16.2.6. Yamamoto Vinita Co., Ltd.
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. SWOT Analysis
16.2.6.4. Strategic Overview
16.2.7. Chongqing Haifu Medical Technology Co., Ltd
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. SWOT Analysis
16.2.7.4. Strategic Overview
16.2.8. InnoMedicus Ltd.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. SWOT Analysis
16.2.8.4. Strategic Overview
16.2.9. Gamida
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. SWOT Analysis
16.2.9.4. Strategic Overview
16.2.10. RanD.
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Product Portfolio
16.2.10.3. SWOT Analysis
16.2.10.4. Strategic Overview
Know More Details About the Report
List of Tables
Table 01: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031
Table 02: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031
Table 03: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2021-2031
Table 04: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031
Table 05: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031
Table 06: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Region, 2021-2031
Table 07: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Country, 2021-2031
Table 08: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031
Table 09: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031
Table 10: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2021-2031
Table 11: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031
Table 12: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031
Table 13: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2031
Table 14: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031
Table 15: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031
Table 16: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2021-2031
Table 17: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031
Table 18: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031
Table 19: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2031
Table 20: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031
Table 21: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031
Table 22: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2021-2031
Table 23: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031
Table 24: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031
Table 25: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2031
Table 26: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031
Table 27: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031
Table 28: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2021-2031
Table 29: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031
Table 30: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031
Table 31: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2031
Table 32: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031
Table 33: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031
Table 34: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2021-2031
Table 35: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031
Table 36: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031
Have a report related query? Speak to us directly
List of Figures
Figure 01: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, 2021-2031
Figure 02: Global Hyperthermia Cancer Treatment Market Value Share, by Device, 2020
Figure 03: Global Hyperthermia Cancer Treatment Market Value Share, by Treatment Method, 2020
Figure 04: Global Hyperthermia Cancer Treatment Market Value Share, by Application, 2020
Figure 05: Global Hyperthermia Cancer Treatment Market Value Share, by End User, 2020
Figure 06: Global Hyperthermia Cancer Treatment Market Value Share, by Region, 2020
Figure 07: Global New Cancer Cases & Deaths, 2017
Figure 08: Incidence of Breast Cancer, by Country
Figure 09: Prevalence of Breast Cancer, by Country
Figure 10: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031
Figure 11: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031
Figure 12: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Infrared Hyperthermia Devices, 2021-2031
Figure 13: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Ultrasound Hyperthermia Devices, 2021-2031
Figure 14: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Microwave Hyperthermia Devices, 2021-2031
Figure 15: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Others, 2021-2031
Figure 16: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031
Figure 17: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2021–2031
Figure 18: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Locoregional, 2021-2031
Figure 19: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Whole-Body, 2021-2031
Figure 20: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031
Figure 21: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031
Figure 22: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Breast Cancer, 2021-2031
Figure 23: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Liver Cancer, 2021-2031
Figure 24: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Soft Tissue Sarcoma, 2021-2031
Figure 25: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Head & Neck Tumors, 2021-2031
Figure 26: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Prostate Cancer, 2021-2031
Figure 27: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Others, 2021-2031
Figure 28: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031
Figure 29: Global Hyperthermia Cancer Treatment Market Attractiveness, by End User, 2021–2031
Figure 30: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Hospitals & Specialty Clinics, 2021-2031
Figure 31: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2021-2031
Figure 32: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Standalone Devices, 2021-2031
Figure 33: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Region, 2021 and 2031
Figure 34: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Region
Figure 35: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021-2031
Figure 36: North America Hyperthermia Cancer Treatment Market Value Share (%), by Country, 2021 and 2031
Figure 37: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country, 2021–2031
Figure 38: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031
Figure 39: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031
Figure 40: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031
Figure 41: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2031
Figure 42: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031
Figure 43: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031
Figure 44: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031
Figure 45: North America Hyperthermia Cancer Treatment Market Attractiveness, by End User, 2021–2031
Figure 46: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021-2031
Figure 47: Europe Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 48: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 49: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031
Figure 50: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031
Figure 51: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031
Figure 52: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2021–2031
Figure 53: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031
Figure 54: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031
Figure 55: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031
Figure 56: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End User, 2021–2031
Figure 57: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021-2031
Figure 58: Asia Pacific Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 59: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 60: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031
Figure 61: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031
Figure 62: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031
Figure 63: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2021–2031
Figure 64: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031
Figure 65: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031
Figure 66: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031
Figure 67: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End User, 2021–2031
Figure 68: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021-2031
Figure 69: Latin America Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 70: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 71: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031
Figure 72: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031
Figure 73: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031
Figure 74: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2021–2031
Figure 75: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031
Figure 76: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031
Figure 77: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031
Figure 78: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End User, 2021–2031
Figure 79: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021-2031
Figure 80: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 81: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 82: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031
Figure 83: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031
Figure 84: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031
Figure 85: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2021–2031
Figure 86: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031
Figure 87: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031
Figure 88: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031
Figure 89: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End User, 2021–2031
Hyperthermia Cancer Treatment Market - Scope of Report
A recent study by Fact.MR on the hyperthermia cancer treatment market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering hyperthermia cancer treatment.
The study also provides the dynamics that are responsible for influencing the future status of the hyperthermia cancer treatment market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the hyperthermia cancer treatment space, along with their product portfolios, enhances the reliability of this comprehensive research study.
Report Summary
The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of hyperthermia cancer treatment solutions across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of hyperthermia cancer treatment solutions during the forecast period. Price point comparison by region with global average price is also considered in the study.
Key Questions Answered in Report
- Which are the most lucrative markets for hyperthermia cancer treatment?
- Which factors will impact the growth of the market over the coming years?
- How will changing trends impact the strategies of market players?
- How can market players capture the low-hanging opportunities across regions?
- Which companies are leading the hyperthermia cancer treatment industry?
- What are the winning strategies of stakeholders in the market?
Analysis on Market Size Evaluation
The market has been analyzed for each market segment in terms of volume (‘000 Units) and value (US$ Mn).
Market estimates at global and regional levels for hyperthermia cancer treatment are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global hyperthermia cancer treatment market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.
Country-specific valuation on demand for hyperthermia cancer treatment has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value and volume for emerging countries has also been included in the report.
In-depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of hyperthermia cancer treatment solutions, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering hyperthermia cancer treatment solutions has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Research Methodology
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the hyperthermia cancer treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.
- FAQs -
Hyperthermia cancer treatment market is poised to surpass US$ 250 million in revenue by 2031, registering a healthy 6% CAGR throughout the forecast period
PYREXAR Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.r.l., Yamamoto Vinita Co. Ltd, Chongqing Haifu Medical Technology Co. Ltd., innoMedicus Ltd. and Gamida-Cell Ltd. and RanD are some prominent hyperthermia device manufacturers
The North American market is slated to accrue significant gains with regard to hyperthermia cancer treatment amid the ever swelling incidence of various types of cancers amongst all sections of the population
- Related Reports -
Natural Gelling Agents Market
Natural Gelling Agents Market is forecast to reach a valuation of US$ 6.33 Bn by 2032. Gelatin as a ...
Natural Flavor Carrier Market
Natural Flavor Carrier Market is projected to grow at steady CAGR rate during 2018-2028. Clean Label...
Natural Skin Care Products Market
The global natural skin care product market is anticipated to secure a market value of USD 13.4 Bn b...
Natural Cheese Market
Natural Cheese Market to reach a valuation of US$ 8 Billion by the end of the year 2022. Goat milk b...
- Our Clients -

- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.